Stock Research: Guardant Health

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Guardant Health

NasdaqGS:GH US40131M1099
67
  • Value
    4
  • Growth
    97
  • Safety
    Safety
    65
  • Combined
    73
  • Sentiment
    57
  • 360° View
    360° View
    67
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Guardant Health, Inc. is a precision oncology company providing insights into disease drivers through advanced blood and tissue tests, real-world data, and AI analytics to improve cancer outcomes across all stages of care. Its main businesses involve screening for early cancer, monitoring for recurrence, and helping doctors select advanced cancer treatments, including Guardant360 LDT, Guardant360 CDx for NSCLC and breast cancer, Guardant360 Tissue, Guardant Reveal, and Guardant360 Response. The description does not specify different regions of operation. In the last fiscal year, the company had a market cap of $5995 million, profits of $449 million, revenue of $739 million, and 1999 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 67 (better than 67% compared with alternatives), overall professional sentiment and financial characteristics for the stock Guardant Health are above average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Guardant Health. The consolidated Value Rank has an attractive rank of 65, which means that the share price of Guardant Health is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 65% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 97, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 57. But the company’s financing is risky with a Safety rank of 4. This means 96% of comparable companies have a safer financing structure than Guardant Health. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 30-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
65 65 6 10
Growth
97 93 82 14
Safety
Safety
4 7 14 26
Sentiment
57 70 37 20
360° View
360° View
67 79 12 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
85 84 72 81
Opinions Change
52 68 47 43
Pro Holdings
n/a 57 10 12
Market Pulse
18 27 29 15
Sentiment
57 70 37 20
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
65 65 6 10
Growth
97 93 82 14
Safety Safety
4 7 14 26
Combined
73 64 10 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
3 3 3 4
Price vs. Earnings (P/E)
22 26 7 3
Price vs. Book (P/B)
100 100 3 11
Dividend Yield
1 1 1 1
Value
65 65 6 10
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
84 76 89 72
Profit Growth
46 60 73 19
Capital Growth
91 81 97 18
Stock Returns
95 95 32 22
Growth
97 93 82 14
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
1 5 5 31
Refinancing
41 51 80 76
Liquidity
7 11 9 9
Safety Safety
4 7 14 26

Similar Stocks

Discover high‑ranked alternatives to Guardant Health and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Cognizant Technology

NasdaqGS:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Cigna

NYSE:CI
Country: USA
Industry: Health Care Services
Size: XX-Large
Full Stock Analysis

TEGNA

NYSE:TGNA
Country: USA
Industry: Broadcasting
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.